Literature DB >> 10452782

Treatment of eosinophilic gastroenteritis with montelukast.

M R Neustrom, C Friesen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10452782     DOI： 10.1016/s0091-6749(99)70404-5

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN： 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  32 in total

Review 1.  Leukotriene receptor antagonist therapy.

Authors:  O J Dempsey
Journal:  Postgrad Med J       Date:  2000-12       Impact factor: 2.401

2.  Eosinophilic gastroenteritis causing pancreatitis and pancreaticobiliary ductal dilation.

Authors:  S Polyak; T A Smith; H Mertz
Journal:  Dig Dis Sci       Date:  2002-05       Impact factor: 3.199

3.  Eosinophilic oesophagitis: treatment using Montelukast.

Authors:  R Sinharay
Journal:  Gut       Date:  2003-08       Impact factor: 23.059

4.  Treatment options for eosinophilic esophagitis: elemental diet.

Authors:  Samer Gawrieh; Reza Shaker
Journal:  Curr Gastroenterol Rep       Date:  2004-06

5.  Eosinophilic gastroenteritis and related eosinophilic disorders.

Authors:  Calman Prussin
Journal:  Gastroenterol Clin North Am       Date:  2014-06       Impact factor: 3.806

Review 6.  Eosinophilic gastroenteritis: epidemiology, diagnosis and management.

Authors:  Seema Khan; Susan R Orenstein
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

Review 7.  Eosinophilic gastroenteritis.

Authors:  Rahim Daneshjoo; Nicholas J Talley
Journal:  Curr Gastroenterol Rep       Date:  2002-10

8.  Treatment of Eosinophilic Esophagitis in Children.

Authors:  Seema Khan; Wendy A. Henderson
Journal:  Curr Treat Options Gastroenterol       Date:  2002-10

Review 9.  Adult eosinophilic gastroenteritis and hypereosinophilic syndromes.

Authors:  Hugh James Freeman
Journal:  World J Gastroenterol       Date:  2008-11-28       Impact factor: 5.742

10.  Montelukast in the treatment of duodenal eosinophilia in children with dyspepsia: effect on eosinophil density and activation in relation to pharmacokinetics.

Authors:  Craig A Friesen; Nancy A Neilan; Jennifer V Schurman; Debra L Taylor; Gregory L Kearns; Susan M Abdel-Rahman
Journal:  BMC Gastroenterol       Date:  2009-05-11       Impact factor: 3.067
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.